This is a double-blind, randomized, placebo-controlled, single ascending dose study to assess
the safety, tolerability, and PK of ACHN-975 in normal healthy volunteers. This study will
take place in the US at one clinical site.
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01597947
Ages eligible for Study
18 Years to 45 Years
Genders eligible for Study
Accepts Healthy Volunteers
Body weight between 40 and 100 kilograms (between ~88 pounds and ~220 pounds)
Use of contraception
Negative tests for alcohol, tobacco, and drugs of abuse Key
History of clinically significant disease
All locations for NCT01597947
United States (1)
Durham, North Carolina, United States, 27705
View full eligibility
Tris trial is registered with FDA with number: NCT01597947. The sponsor of the trial is Achaogen, Inc. and it is looking for 50 volunteers for the current phase.
Official trial title: A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous (IV) ACHN-975 in Normal Healthy Volunteers
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.